FIELD: medicine, pharmaceutics.
SUBSTANCE: what is described is the new compound 6-[(4-methyl-1-1-piperazinyl)methyl]-indolo[1',7':1,2,3]pyrrolo[3',4':6,7]azepino[4,5-6]indole-1,3(2H, 10H)-dione of formula , a method for preparing it and the use on the basis of observed activity as the Pim-1 proteinkinase inhibitor as an antitumour agent.
EFFECT: use of the Pim-1 proteinkinase inhibitor as an antitumour agent.
3 cl, 1 ex
Title | Year | Author | Number |
---|---|---|---|
PHARMACEUTICAL COMPOSITION BASED ON 6-[(4-METHYL-1-1-PIPERAZINYL)METHYL]-INDOLO[1',7':1,2,3]PYRROLO[3',4':6,7]AZEPINO[4,5-b]INDOLE-1,3(2H,10 H)-DIONE AS ANTI-TUMOUR MEDICATION | 2013 |
|
RU2523387C1 |
METHOD OF SYNTHESIS OF INDOLO[1',7':1,2,3]PIRROLO[3',4':6,7]AZEPINO[4,5-B]INDOL-1,3(2H,10H)-DIONE | 2017 |
|
RU2648039C1 |
4-(1-(4-(4-METHOXYPHENYLTHIO)-2,5-DIOXO-2,5-DIHYDRO-1H-PYRRO-3-YL)-1H-INDOL-3-YL)BUTYLCARBAMIMIDOTHIOATE AND METHOD FOR USING IT | 2009 |
|
RU2441000C2 |
METHOD FOR PRODUCING 4-AROYL-1-(2-HYDROXYARYL)-5-(1H-INDOL-3-YL)-1,3-DIHYDRO-2H-PYRROLE-2,3-DIONES WITH ANTIMICROBIAL ACTIVITY | 2023 |
|
RU2806040C1 |
2-(2-OXOINDOLIN-3-YLIDENE)METHYL-5-(2-HYDROXY-3-MORPHOLIN-4-YLPROPYL)-6,7-DIHYDRO-1-H-PYRROLE[3,2-C]PYRIDIN-4(5H)-ONE COMPOUNDS AND USE THEREOF AS PROTEIN KINASE INHIBITORS | 2008 |
|
RU2472792C2 |
3-METHYL-8-(4-METHOXYPHENYL)-2-THIOXO-3A,5-DI(4-TOLYL)-1,2,3,3A-TETRAHYDRO-6H-PYRROLO[2',3':3,4]FURO[2,3-D]IMIDAZOLE-6,7(8H)-DIONE EXHIBITING ANTIMICROBIAL ACTIVITY AND METHOD FOR PRODUCTION THEREOF | 2022 |
|
RU2785197C1 |
HETEROCYCLIC NITROGEN PYRROLE DERIVATIVES, PRODUCING THEM AND PHARMACEUTICAL APPLICATION | 2008 |
|
RU2473543C2 |
N- (PHENYLSULPHONYL) BENZAMIDES AND RELATED COMPOUNDS AS BCL-2 INHIBITORS | 2017 |
|
RU2744358C2 |
1-SUBSTITUTED 3-(2-CHLORO-1H-INDOL-3-YL)-4-PHENYL-1H-PYRROLE-2,5-DIONES AND USE THEREOF IN PHOTOCHEMICAL GENERATION OF STABLE FLUORESCENT COMPOUNDS AND 2,8-SUBSTITUTED BENZO[a]PYRROLO[3,4-c]CARBAZOLE-1,3-(2H,8H)-DIONES AND USE THEREOF AS FLUOROPHORES | 2009 |
|
RU2402547C1 |
N-(PHENYLSULFONYL)BENZAMIDES AND RELATED COMPOUNDS AS BCL-2 INHIBITORS | 2017 |
|
RU2722560C1 |
Authors
Dates
2012-11-10—Published
2011-03-09—Filed